Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999–2007
Authors:
- Timothy J. RobinsonTRTimothy J. Robinson
- Timothy M. ZagarTZTimothy M. Zagar
- Charles D. ScalesCSCharles D. Scales
- Lesley H. CurtisLCLesley H. Curtis
- Shelby D. ReedSRShelby D. Reed
- W. Robert LeeWLW. Robert Lee
- Kevin A. SchulmanKSKevin A. Schulman
- 1 April 2012
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 82 (5) , e781-e786
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate CancerJournal of Clinical Oncology, 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Overtreatment of men with low‐risk prostate cancer and significant comorbidityCancer, 2010
- Reimbursement Policy and Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2010
- Outcomes of Localized Prostate Cancer Following Conservative ManagementJAMA, 2009
- National Health Spending By Medical Condition, 1996–2005Health Affairs, 2009
- Patterns of Care for Radical Prostatectomy in the United States From 2003 to 2005Journal of Urology, 2008
- Utilization and Outcomes of Minimally Invasive Radical ProstatectomyJournal of Clinical Oncology, 2008
- Is Proton Beam Therapy Cost Effective in the Treatment of Adenocarcinoma of the Prostate?Journal of Clinical Oncology, 2007
- Geographic and Socioeconomic Variation in the Treatment of Prostate CancerJournal of Clinical Oncology, 2005